Essex Financial Services, Inc. Abbott Laboratories Transaction History

Essex Financial Services, Inc.

$1.43 Billion
Q2 2025

A detailed history of Essex Financial Services, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Essex Financial Services, Inc. holds 24,599 shares of ABT stock, worth $3.22 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

24,599

Previous 24,225 1.54%

Holding current value

$3.22 Million

Previous $3.21 Million 4.11%

% of portfolio

0.23%

Previous 0.24%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	BUY	$123.95 - $138.08 $46,357 - $51,641	374 Added 1.54%	24,599 $3.35 Million
Q1 2025 Apr 25, 2025	SELL	$111.1 - $140.22 $23,442 - $29,586	-211 Reduced 0.86%	24,225 $3.21 Million
Q4 2024 Jan 29, 2025	BUY	$111.93 - $119.39 $13,207 - $14,088	118 Added 0.49%	24,436 $2.76 Million
Q3 2024 Oct 24, 2024	BUY	$100.07 - $118.13 $4,303 - $5,079	43 Added 0.18%	24,318 $2.77 Million
Q2 2024 Aug 09, 2024	BUY	$100.73 - $112.44 $9,267 - $10,344	92 Added 0.38%	24,275 $2.52 Million
Q2 2024 Jul 31, 2024	BUY	$100.73 - $112.44 $416,014 - $464,377	4,130 Added 20.6%	24,183 $2.51 Million
Q1 2024 Apr 23, 2024	BUY	$109.52 - $120.96 $130,876 - $144,547	1,195 Added 6.34%	20,053 $2.28 Million
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $270 - $331	-3 Reduced 0.02%	18,858 $2.08 Million
Q3 2023 Nov 15, 2023	SELL	$95.53 - $114.62 $36,301 - $43,555	-380 Reduced 1.97%	18,861 $1.83 Million
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $4,635 - $5,165	-46 Reduced 0.24%	19,241 $2.1 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $77,294 - $90,979	-798 Reduced 3.97%	19,287 $1.95 Million
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $15,209 - $17,843	160 Added 0.8%	20,085 $2.21 Million
Q3 2022 Nov 07, 2022	BUY	$96.76 - $112.03 $290 - $336	3 Added 0.02%	19,925 $1.93 Million
Q2 2022 Aug 01, 2022	BUY	$102.07 - $123.37 $51,239 - $61,931	502 Added 2.58%	19,922 $2.17 Million
Q1 2022 Apr 21, 2022	SELL	$114.02 - $139.04 $79,015 - $96,354	-693 Reduced 3.45%	19,420 $2.3 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $1,270 - $1,556	11 Added 0.05%	20,113 $2.83 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $659,712 - $729,834	5,655 Added 39.14%	20,102 $2.38 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $412,830 - $486,376	-3,793 Reduced 20.79%	14,447 $1.73 Million
Q4 2020 Feb 05, 2021	SELL	$105.0 - $114.42 $21,210 - $23,112	-202 Reduced 1.1%	18,240 $2 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $72,578 - $88,141	792 Added 4.49%	18,442 $2.01 Million
Q2 2020 Aug 06, 2020	BUY	$76.57 - $98.0 $30,704 - $39,298	401 Added 2.32%	17,650 $1.61 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $279,046 - $408,042	-4,442 Reduced 20.48%	17,249 $1.36 Million
Q4 2019 Jan 30, 2020	BUY	$78.51 - $87.4 $100,178 - $111,522	1,276 Added 6.25%	21,691 $1.84 Million
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $3,846 - $4,170	-47 Reduced 0.23%	20,415 $1.71 Million
Q2 2019 Jul 30, 2019	SELL	$72.88 - $85.0 $35,492 - $41,395	-487 Reduced 2.32%	20,462 $1.72 Million
Q1 2019 May 02, 2019	SELL	$66.22 - $80.06 $40,394 - $48,836	-610 Reduced 2.83%	20,949 $1.68 Million
Q4 2018 Feb 07, 2019	SELL	$65.56 - $74.27 $542,377 - $614,435	-8,273 Reduced 27.73%	21,559 $1.56 Million
Q3 2018 Nov 05, 2018	BUY	$60.81 - $73.36 $22,621 - $27,289	372 Added 1.26%	29,832 $2.19 Million
Q2 2018 Aug 07, 2018	SELL	$57.57 - $63.54 $10,765 - $11,881	-187 Reduced 0.63%	29,460 $1.8 Million
Q1 2018 May 03, 2018	BUY	$56.27 - $63.62 $16,318 - $18,449	290 Added 0.99%	29,647 $1.78 Million
Q4 2017 Feb 07, 2018	SELL	$53.68 - $57.47 $40,206 - $43,045	-749 Reduced 2.49%	29,357 $1.68 Million
Q3 2017 Nov 03, 2017	SELL	$48.06 - $53.64 $27,201 - $30,360	-566 Reduced 1.85%	30,106 $1.61 Million
Q2 2017 Aug 07, 2017	BUY	N/A	30,672	30,672 $1.49 Million

Others Institutions Holding ABT

# of Institutions

3,580

Shares Held

1.39B

Call Options Held

9.32M

Put Options Held

8.78M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Essex Financial Services, Inc. with notifications on news.

Account

Essex Financial Services, Inc. Abbott Laboratories Transaction History